WallStreetZenWallStreetZen

NASDAQ: ENTX
Entera Bio Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ENTX

Based on 1 analyst offering 12 month price targets for Entera Bio Ltd

Min Forecast
$10.00+437.63%
Avg Forecast
$10.00+437.63%
Max Forecast
$10.00+437.63%

Should I buy or sell ENTX stock?

Based on 1 analyst offering ratings for Entera Bio Ltd.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ENTX stock forecasts and price targets.

ENTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-03-18

1 of 1

Forecast return on equity

Is ENTX forecast to generate an efficient return?

Company
N/A
Industry
140.91%
Market
90.47%

Forecast return on assets

Is ENTX forecast to generate an efficient return on assets?

Company
N/A
Industry
32.45%

ENTX earnings per share forecast

What is ENTX's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$0.55

ENTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ENTX$1.86$10.00+437.63%Buy
PLRX$1.38$3.92+183.84%Hold
CLYM$1.26$10.00+693.65%Buy
JSPR$5.58$51.20+817.56%Buy
ORMP$2.12N/AN/A
View Top Biotech Stocks

Entera Bio Stock Forecast FAQ

Is Entera Bio Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ENTX) stock is to Buy ENTX stock.

Out of 1 analyst, 0 (0%) are recommending ENTX as a Strong Buy, 1 (100%) are recommending ENTX as a Buy, 0 (0%) are recommending ENTX as a Hold, 0 (0%) are recommending ENTX as a Sell, and 0 (0%) are recommending ENTX as a Strong Sell.

If you're new to stock investing, here's how to buy Entera Bio stock.

What is ENTX's earnings growth forecast for 2025-2025?

(NASDAQ: ENTX) Entera Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.6%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.33%.

Entera Bio's earnings in 2025 is -$10,091,000.

In 2025, ENTX is forecast to generate -$24,998,692 in earnings, with the lowest earnings forecast at -$24,998,692 and the highest earnings forecast at -$24,998,692.

What is ENTX's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: ENTX) forecast ROE is N/A, which is considered weak.

What is ENTX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ENTX price target, the average ENTX price target is $10.00, with the highest ENTX stock price forecast at $10.00 and the lowest ENTX stock price forecast at $10.00.

The Wall Street analyst predicted that Entera Bio's share price could reach $10.00 by Mar 18, 2026. The average Entera Bio stock price prediction forecasts a potential upside of 437.63% from the current ENTX share price of $1.86.

What is ENTX's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: ENTX) Entera Bio's current Earnings Per Share (EPS) is -$0.26. In 2025, ENTX's EPS is forecast to hit -$0.55 (min: -$0.55, max: -$0.55).

What is ENTX's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: ENTX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 32.45%.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.